[Molecular-targeted therapy for malignant glioma]

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Context:

• Cancer treatment has evolved beyond cytotoxic and anti-endocrine drugs.
• Molecular-targeted therapies aim to disrupt cancer-specific pathways.
• Identifying and validating drug targets is crucial for developing effective cancer treatments.

Purpose:

• To review the development of molecular-targeted, non-cytotoxic agents for glioma treatment.
• To highlight lessons learned from these novel drug development processes.
• To propose future directions for molecular-targeted therapy in clinical settings.

Summary:

• Molecular-targeted therapies are increasingly used in cancer treatment, focusing on molecular pathways.
• Key targets include cell surface receptors, signal transduction pathways, and the tumor microenvironment.
• This review specifically examines targeted agents investigated in glioma, offering insights for future drug development.

Impact:

• Provides a comprehensive overview of molecular-targeted therapies in glioma research.
• Offers valuable lessons for the development of novel, targeted anticancer drugs.
• Suggests new avenues for clinical development of molecular-targeted therapies.